COX-2 as a determinant of lower disease-free survival for patients affected by ameloblastoma

COX-2 as a determinant of lower disease-free survival for patients affected by ameloblastoma

M.A.P. Montezuma, F.P. Fonseca, B.M. Benites, C.D. Soares, G.K. do Amaral-Silva, O.P. de Almeida, F.A. Soares, R.L. Pagano, E.R. Fregnani

ARTIGO

Inglês

Ameloblastoma is a locally aggressive neoplasm with a poorly understood pathogenesis. Therefore, the aim of this study is to investigate whether COX-2 expression is associated with ameloblastoma microvascular density (MVD) and with tumor aggressiveness. Sixty-three cases of primary ameloblastomas...

Fechado

COX-2 as a determinant of lower disease-free survival for patients affected by ameloblastoma

M.A.P. Montezuma, F.P. Fonseca, B.M. Benites, C.D. Soares, G.K. do Amaral-Silva, O.P. de Almeida, F.A. Soares, R.L. Pagano, E.R. Fregnani


										

COX-2 as a determinant of lower disease-free survival for patients affected by ameloblastoma

M.A.P. Montezuma, F.P. Fonseca, B.M. Benites, C.D. Soares, G.K. do Amaral-Silva, O.P. de Almeida, F.A. Soares, R.L. Pagano, E.R. Fregnani

    Fontes

    Pathology, research and practice

    Vol. 214, no. 6 (June, 2018), p. 907-913